Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors--implications for dose-sparing combination therapies.
about
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.Dimethylfumarate effectively inhibits lymphangiogenesis via p21 induction and G1 cell cycle arrest.Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis.Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS
P2860
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors--implications for dose-sparing combination therapies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Mutually enhancing anti-inflam ...... sparing combination therapies.
@en
Mutually enhancing anti-inflam ...... sparing combination therapies.
@nl
type
label
Mutually enhancing anti-inflam ...... sparing combination therapies.
@en
Mutually enhancing anti-inflam ...... sparing combination therapies.
@nl
prefLabel
Mutually enhancing anti-inflam ...... sparing combination therapies.
@en
Mutually enhancing anti-inflam ...... sparing combination therapies.
@nl
P2093
P2860
P356
P1476
Mutually enhancing anti-inflam ...... sparing combination therapies.
@en
P2093
Anike Lockmann
Anna-Carina Hund
Michael P Schön
P2860
P304
P356
10.1111/EXD.12892
P577
2016-01-12T00:00:00Z